Risultati della ricerca - Frank Mußhoff

  • Mostra 1 - 6 risultati su 6
Raffina i risultati
  1. 1
    Knock-Out Drugs

    Knock-Out Drugs di Burkhard Madea, Frank Mußhoff

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use

    Review of Biologic Matrices (Urine, Blood, Hair) as Indicators of Recent or Ongoing Cannabis Use di Frank Mußhoff, Burkhard Madea

    Pubblicazione 2006
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    CYP2D6 Genotype Dependent Oxycodone Metabolism in Postoperative Patients

    CYP2D6 Genotype Dependent Oxycodone Metabolism in Postoperative Patients di Ulrike M. Stamer, Lan Zhang, Malte Book, Lutz Lehmann, Frank Stüber, Frank Mußhoff

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    “Spice”-related deaths in and around Munich, Germany: A retrospective look at the role of synthetic cannabinoid receptor agonists in our post-mortem cases over a seven-year period (2014–2020)

    “Spice”-related deaths in and around Munich, Germany: A retrospective look at the role of synthetic cannabinoid receptor agonists in our post-mortem cases over a seven-year period... di Olwen Groth, Gabriele Roider, Verena Angerer, Jan Schäper, Matthias Graw, Frank Mußhoff, Volker Auwärter

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome

    Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome di Kirsten Müller‐Vahl, Laura Bîndilă, Beat Lutz, Frank Mußhoff, Thomas Skripuletz, Charlotte Baumgaertel, Kurt‐Wolfram Sühs

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market

    ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market di Arianna Giorgetti, Annette Zschiesche, Olwen Groth, Belal Haschimi, Martin Scheu, Guido Pelletti, Paolo Fais, Frank Mußhoff, Volker Auwärter

    Pubblicazione 2024
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: